+231.7%
ORCL vs CVS
+57.5%
+174.2%
-64.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | CVS | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -3.1% | -0.3% | -2.8% |
| 7D | -2.5% | -3.6% | +1.1% | -1.7% |
| 30D | -10.3% | -6.4% | -3.9% | -9.2% |
| 3M | -21.3% | -8.1% | -13.2% | -20.2% |
| 6M | -40.0% | -9.3% | -30.7% | -39.3% |
| YTD | -40.2% | +11.4% | -51.7% | -43.1% |
| 1Y | -47.0% | +12.8% | -59.8% | -49.8% |
| 3Y | +3.3% | +39.6% | -36.4% | -10.4% |
| 5Y | +29.1% | +9.4% | +19.7% | +20.8% |
| 10Y | +231.7% | +57.7% | +174.0% | +153.4% |
| All | +231.7% | +57.5% | +174.2% | +153.4% |
Cumulative growth
Daily Returns
Daily percentage return beside CVS.
Daily Out/Under-Performance
Portfolio return minus CVS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CVS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded CVS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling